These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20373324)

  • 1. Adenosine and 2'-deoxyadenosine modified with boron cluster pharmacophores as new classes of human blood platelet function modulators.
    Bednarska K; Olejniczak AB; Wojtczak BA; Sułowska Z; Leśnikowski ZJ
    ChemMedChem; 2010 May; 5(5):749-56. PubMed ID: 20373324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adenosine modified with a boron cluster pharmacophore on reactive oxygen species production by human neutrophils.
    Bednarska K; Olejniczak AB; Piskala A; Klink M; Sulowska Z; Lesnikowski ZJ
    Bioorg Med Chem; 2012 Nov; 20(22):6621-9. PubMed ID: 23063523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-deoxyadenosine bearing hydrophobic carborane pharmacophore.
    Olejniczak A; Wojtczak B; Lesnikowski ZJ
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1611-3. PubMed ID: 18066837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents.
    Manolopoulos P; Glenn JR; Fox SC; May JA; Dovlatova NL; Tang SW; Thomas NR; Ralevic V; Heptinstall S
    Platelets; 2008 Mar; 19(2):134-45. PubMed ID: 18297551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine inhibition of adenosine diphosphate and thrombin-induced monocyte-platelet aggregates in cardiac syndrome X.
    Aurigemma C; Scalone G; Fattorossi A; Sestito A; Lanza GA; Crea F
    Thromb Res; 2009 May; 124(1):116-20. PubMed ID: 19185336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5'-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors.
    Cristalli G; Podda GM; Costanzi S; Lambertucci C; Lecchi A; Vittori S; Volpini R; Zighetti ML; Cattaneo M
    J Med Chem; 2005 Apr; 48(8):2763-6. PubMed ID: 15828813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
    Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooling and freezing damage platelet membrane integrity.
    Reid TJ; LaRussa VF; Esteban G; Clear M; Davies L; Shea S; Gorogias M
    Cryobiology; 1999 May; 38(3):209-24. PubMed ID: 10328911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function.
    Natarajan P; May JA; Sanderson HM; Zabe M; Spangenberg P; Heptinstall S
    Platelets; 2000 Dec; 11(8):467-76. PubMed ID: 11177446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine priming reduces ADP-induced P-selectin expression and platelet-leukocyte aggregation.
    Huang GS; Lin TC; Wang JY; Ku CH; Ho ST; Li CY
    Acta Anaesthesiol Taiwan; 2009 Jun; 47(2):56-61. PubMed ID: 19527965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.
    Norgard NB; Saya S; Hann CL; Hennebry TA; Schechter E; Dale GL
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):536-9. PubMed ID: 19034031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.